Eli Lilly’s Tabalumab Fails over Efficacy in Phase 3 Trial

Eli Lilly’s Tabalumab Fails over Efficacy in Phase 3 Trial

Though, tabalumab's Phase II clinical studies showed success and proved effective, a recent report has revealed that Eli Lilly and Company's human monoclonal antibody failed in terms of meeting efficacy objectives in a next-stage trial.

Of total three Phase 3 rheumatoid arthritis registration studies, one study of the anti-BAFF monoclonal antibody failed, which the researchers say, was totally unexpected. However, the failure is in no way related to safety concerns.

Therefore, as per the findings, patients currently involved in other studies of tabalumab RA would continue the treatment. Lilly would also be working towards the development of additional treatment options so that patients with autoimmune diseases could have an option.

It has been told that the company would evaluate the candidate in two other studies related to Phase 3 RA registration following the open-label extension study as well as other smaller studies. Since, the company is of the belief that it does not have sufficient data to gain U. S. marketing clearance.

"We remain committed to patients with rheumatoid arthritis and lupus and will move rapidly to evaluate the impact of these data on the overall tabalumab clinical development programme", sources quoted vice president for Lilly autoimmune product development Eiry Roberts as saying.


FrenchTribune Specials

21 Elk Drown in Echo Canyon Reservoir

Colorado Parks & Wildlife spokesman Matt Robbins has said cracking of ice caused death of nearly 21 elk. The incident probably happened Sunday night or early Monday morning, Robbins said. The herd drowned in Echo Canyon Reservoir, they added.

As per officials, the herd might have made it out onto the thin ice sheet almost 50 feet...

Most Popular

Google persuading Firefox users to ditch Yahoo as their default search engine

In an apparent effort to retain its dominance in the...

BMW, VW team up to install 100 high-speed charging stations in 2015

In an announcement made on Thursday, automakers BMW and...

Property of Over £1bn to Fall into Sea Due to Coastal Erosion

According to an unpublished Environment Agency (EA)...

Ashwin Vasavada succeeds John Grotzinger as NASA's New Curiosity Rover Science C

NASA has appointed Ashwin Vasavada as the new Curiosity...

Poll

Can Greece Come out of Economic Problems: